Page results
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
This page is for patients who have been referred by their GP to a gynaecology specialist because their symptoms need further tests.
-
A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
File results
-
FOI/2024/0482 - Medical device/ enterprise application Integration/ data warehouse systems
-
FOI/2024/0368 - Treatment in renal cell carcinoma
-
FOI/2023/0418 - GIDS service patient referrals and treatment
-
FOI/2022/0655 - GIDS patients who have been prescribed GnRH analogues
-
FOI/2024/0480 - Freedom of Information (FOI) requests 2020/21-2023/24
-
FOI/2024/0479 - Applications or systems deployed on Microsoft Azure Cloud
-
FOI/2024/0478 - Elective operations cancelled for non-clinical reasons 2021/22-2023/24
-
FOI/2024/0473 - Elective operations cancelled for non-clinical reasons 2023/24
-
FOI/2024/0254 - Urothelial and endometrial cancer treatments
-
FOI/2024/0246 - Gastric and gastro-oesophageal/ non-small cell lung/ renal cell carcinoma cancer treatments